A critical role for human caspase-4 in endotoxin sensitivity

Journal of Immunology

Volumn 193, Issue 1, 2014, Pages 335-343

  Kajiwara, Yuji ^a   Schiff, Tamar ^b   Voloudakis, Georgios ^a,d   Gama Sosa, Miguel A ^a,c   Elder, Gregory ^a,c   Bozdagi, Ozlem ^a   Buxbaum, Joseph D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 4; CRYOPYRIN; ENDOTOXIN; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 11; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; LYMPHOTOXIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; HYPERSENSITIVITY; LETHALITY; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CASPASES; CASPASES, INITIATOR; CELL LINE; ENZYME INDUCTION; HUMANS; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, KNOCKOUT;

EID: 84903555072     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303424     Document Type: Article

References (54)

1. Lamkanfi, M., and V. M. Dixit. 2012. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 28: 137-161.
2. Krysko, D. V., A. D. Garg, A. Kaczmarek, O. Krysko, P. Agostinis, and P. Vandenabeele. 2012. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12: 860-875.
3. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
4. Franchi, L., R. Muñoz-Planillo, and G. Núñez. 2012. Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 13: 325-332.
5. Rathinam, V. A., S. K. Vanaja, and K. A. Fitzgerald. 2012. Regulation of inflammasome signaling. Nat. Immunol. 13: 333-342.
6. Kayagaki, N., S. Warming, M. Lamkanfi, L. Vande Walle, S. Louie, J. Dong, K. Newton, Y. Qu, J. Liu, S. Heldens, et al. 2011. Non-canonical inflammasome activation targets caspase-11. Nature 479: 117-121.
7. Broz, P., T. Ruby, K. Belhocine, D. M. Bouley, N. Kayagaki, V. M. Dixit, and D. M. Monack. 2012. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490: 288-291.
8. Dinarello, C. A. 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117: 3720-3732.
9. Kastner, D. L., I. Aksentijevich, and R. Goldbach-Mansky. 2010. Autoinflammatory disease reloaded: a clinical perspective. Cell 140: 784-790.
10. Wen, H., D. Gris, Y. Lei, S. Jha, L. Zhang, M. T. Huang, W. J. Brickey, and J. P. Ting. 2011. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12: 408-415.
11. Duewell, P., H. Kono, K. J. Rayner, C. M. Sirois, G. Vladimer, F. G. Bauernfeind, G. S. Abela, L. Franchi, G. Nuñez, M. Schnurr, et al. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361.
12. Heneka, M. T., M. P. Kummer, A. Stutz, A. Delekate, S. Schwartz, A. Vieira-Saecker, A. Griep, D. Axt, A. Remus, T. C. Tzeng, et al. 2013. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493: 674-678.
13. Halle, A., V. Hornung, G. C. Petzold, C. R. Stewart, B. G. Monks, T. Reinheckel, K. A. Fitzgerald, E. Latz, K. J. Moore, and D. T. Golenbock. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9: 857-865.
14. Lamkanfi, M., A. Sarkar, L. Vande Walle, A. C. Vitari, A. O. Amer, M. D. Wewers, K. J. Tracey, T. D. Kanneganti, and V. M. Dixit. 2010. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 185: 4385-4392.
15. Vandanmagsar, B., Y. H. Youm, A. Ravussin, J. E. Galgani, K. Stadler, R. L. Mynatt, E. Ravussin, J. M. Stephens, and V. D. Dixit. 2011. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17: 179-188.
16. Mestas, J., and C. C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172: 2731-2738.
17. Brade, H. 1999. Endotoxin in Health and Disease. Marcel Dekker, Inc., New York.
18. Wichterman, K. A., A. E. Baue, and I. H. Chaudry. 1980. Sepsis and septic shock-a review of laboratory models and a proposal. J. Surg. Res. 29: 189-201.
19. Seok, J., H. S. Warren, A. G. Cuenca, M. N. Mindrinos, H. V. Baker, W. Xu, D. R. Richards, G. P. McDonald-Smith, H. Gao, L. Hennessy, et al Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110: 3507-3512.
20. Tracey, K. J. 2007. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117: 289-296.
21. Dinarello, C. A., A. Simon, and J. W. van der Meer. 2012. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11: 633-652.
22. Wang, S., M. Miura, Y. K. Jung, H. Zhu, E. Li, and J. Yuan. 1998. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92: 501-509.
23. Rathinam, V. A., S. K. Vanaja, L.Waggoner, A. Sokolovska, C. Becker, L. M. Stuart, J. M. Leong, and K. A. Fitzgerald. 2012. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150: 606-619.
24. Wang, S., M. Miura, Y-k. Jung, H. Zhu, V. Gagliardini, L. Shi, A. H. Greenberg, and J. Yuan. 1996. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 271: 20580-20587.
25. Lin, X. Y., M. S. Choi, and A. G. Porter. 2000. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma. J. Biol. Chem. 275: 39920-39926.
26. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proILbeta. Mol. Cell 10: 417-426.
27. Sollberger, G., G. E. Strittmatter, M. Kistowska, L. E. French, and H. D. Beer. 2012. Caspase-4 is required for activation of inflammasomes. J. Immunol. 188: 1992-2000.
28. Saleh, M., J. P. Vaillancourt, R. K. Graham, M. Huyck, S. M. Srinivasula, E. S. Alnemri, M. H. Steinberg, V. Nolan, C. T. Baldwin, R. S. Hotchkiss, et al. 2004. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429: 75-79.
29. Saleh, M., J. C. Mathison, M. K. Wolinski, S. J. Bensinger, P. Fitzgerald, N. Droin, R. J. Ulevitch, D. R. Green, and D. W. Nicholson. 2006. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 440: 1064-1068.
30. Kang, S. J., S. Wang, H. Hara, E. P. Peterson, S. Namura, S. Amin-Hanjani, Z. Huang, A. Srinivasan, K. J. Tomaselli, N. A. Thornberry, et al. 2000. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell Biol. 149: 613-622.
31. Olofsson, C. S., A. Salehi, C. Holm, and P. Rorsman. 2004. Palmitate increases L-type Ca2+ currents and the size of the readily releasable granule pool in mouse pancreatic beta-cells. J. Physiol. 557: 935-948.
32. Weischenfeldt, J., and B. Porse. 2008. Bone Marrow-Derived Macrophages (BMM): Isolation and Applications. CSH Protoc. 2008: pdb prot5080.
33. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld, et al. 1995. Mice deficient in IL-1 betaconverting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80: 401-411.
34. Hagar, J. A., D. A. Powell, Y. Aachoui, R. K. Ernst, and E. A. Miao. 2013. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341: 1250-1253.
35. Kayagaki, N., M. T. Wong, I. B. Stowe, S. R. Ramani, L. C. Gonzalez, S. Akashi-Takamura, K. Miyake, J. Zhang, W. P. Lee, A. Muszynski, et al. 2013. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341: 1246-1249.
36. Copeland, S., H. S. Warren, S. F. Lowry, S. E. Calvano, and D. Remick; Inflammation and the Host Response to Injury Investigators. 2005. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12: 60-67.
37. Vanden Berghe, T., D. Demon, P. Bogaert, B. Vandendriessche, A. Goethals, B. Depuydt, M. Vuylsteke, R. Roelandt, E. Van Wonterghem, J. Vandenbroecke, et al. 2014. Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am. J. Respir. Crit. Care Med. 189: 282-291.
38. Nickles, D., C. Falschlehner, M. Metzig, and M. Boutros. 2012. A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha signaling. Mol. Cell. Biol. 32: 3372-3381.
39. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267: 2000-2003.
40. Ghayur, T., S. Banerjee, M. Hugunin, D. Butler, L. Herzog, A. Carter, L. Quintal, L. Sekut, R. Talanian, M. Paskind, et al. 1997. Caspase-1 processes IFN-γammainducing factor and regulates LPS-induced IFN-γamma production. Nature 386: 619-623.
41. Sommer, F., and F. Bäckhed. 2013. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 11: 227-238.
42. Erridge, C., T. Attina, C. M. Spickett, and D. J. Webb. 2007. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86: 1286-1292.
43. Cani, P. D., J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
44. Rao, R. 2009. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50: 638-644.
45. Manco, M. 2009. Endotoxin as a missed link among all the metabolic abnormalities in the metabolic syndrome. Atherosclerosis 206: 36, author reply 37.
46. Holmes, C., C. Cunningham, E. Zotova, J. Woolford, C. Dean, S. Kerr, D. Culliford, and V. H. Perry. 2009. Systemic inflammation and disease progression in Alzheimer disease. Neurology 73: 768-774.
47. Duncan, B. B., M. I. Schmidt, J. S. Pankow, C. M. Ballantyne, D. Couper, A. Vigo, R. Hoogeveen, A. R. Folsom, and G. Heiss; Atherosclerosis Risk in Communities Study. 2003. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52: 1799-1805.
48. Mehta, N. N., F. C. McGillicuddy, P. D. Anderson, C. C. Hinkle, R. Shah, L. Pruscino, J. Tabita-Martinez, K. F. Sellers, M. R. Rickels, and M. P. Reilly. 2010. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59: 172-181.
49. Pussinen, P. J., A. S. Havulinna, M. Lehto, J. Sundvall, and V. Salomaa. 2011.Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34: 392-397.
50. Reichenberg, A., R. Yirmiya, A. Schuld, T. Kraus, M. Haack, A. Morag, and T. Pollmächer. 2001. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58: 445-452.
51. Netea, M. G., C. A. Nold-Petry, M. F. Nold, L. A. Joosten, B. Opitz, J. H. van der Meer, F. L. van de Veerdonk, G. Ferwerda, B. Heinhuis, I. Devesa, et al. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113: 2324-2335.
52. Ward, J. R., P. W. West, M. P. Ariaans, L. C. Parker, S. E. Francis, D. C. Crossman, I. Sabroe, and H. L. Wilson. 2010. Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms. J. Biol. Chem. 285: 23147-23158.
53. Druilhe, A., S. M. Srinivasula, M. Razmara, M. Ahmad, and E. S. Alnemri. 2001. Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ. 8: 649-657.
54. Lamkanfi, M., G. Denecker, M. Kalai, K. D'hondt, A. Meeus, W. Declercq, X. Saelens, and P. Vandenabeele. 2004. INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation. J. Biol. Chem. 279: 51729-51738.